Literature DB >> 12687892

Mouse models orthologous to FGFR3-related skeletal dysplasias.

Steven G Brodie1, Chu-Xia Deng.   

Abstract

Fibroblast growth factor receptor 3 (FGFR3) is one of the membrane bound tyrosine kinases that mediate the actions of fibroblast growth factor (FGF) family members. Missense mutations in the coding regions of FGFR3 have been identified in allelic forms of short-limbed dwarfism. Using gene targeting, we demonstrated that Fgfr3 plays an essential role in endochondral ossification and that a loss-of-function mutation causes accelerated and prolonged long bone growth. Using a number of molecular genetic approaches, we also have introduced into the mouse genome a series of mutations that correspond to the missense mutations identified in individuals with achondroplasia and thanatophoric dysplasia. These mouse models mimic the human condition and can be used for further studies to identify and characterize in vivo changes associated with various Fgfr3 mutations. In addition, these models may be beneficial in future studies to attempt novel treatment strategies for short-limbed dwarfism.

Entities:  

Mesh:

Substances:

Year:  2003        PMID: 12687892     DOI: 10.1080/pdp.22.1.87.103

Source DB:  PubMed          Journal:  Pediatr Pathol Mol Med        ISSN: 1522-7952


  3 in total

1.  Phosphoproteomics of Fibroblast Growth Factor 1 (FGF1) Signaling in Chondrocytes: Identifying the Signature of Inhibitory Response.

Authors:  Jessica R Chapman; Olga Katsara; Rachel Ruoff; David Morgenstern; Shruti Nayak; Claudio Basilico; Beatrix Ueberheide; Victoria Kolupaeva
Journal:  Mol Cell Proteomics       Date:  2017-03-15       Impact factor: 5.911

2.  Dusp6 (Mkp3) is a negative feedback regulator of FGF-stimulated ERK signaling during mouse development.

Authors:  Chaoying Li; Daryl A Scott; Ekaterina Hatch; Xiaoyan Tian; Suzanne L Mansour
Journal:  Development       Date:  2007-01       Impact factor: 6.868

3.  Canine fibroblast growth factor receptor 3 sequence is conserved across dogs of divergent skeletal size.

Authors:  Logan B Smith; Danika L Bannasch; Amy E Young; Deborah I Grossman; Janelle M Belanger; Anita M Oberbauer
Journal:  BMC Genet       Date:  2008-10-21       Impact factor: 2.797

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.